Antibody highly specific for diffuse systemic sclerosis (scleroderma).
Interstitial Lung Disease
Interstitial lung disease (ILD) is a group of conditions that cause inflammation and scarring (fibrosis) of the lung tissue around the air sacs. The scarring makes the lungs stiff and makes it harder to get oxygen into the blood. Causes include autoimmune and connective tissue diseases such as systemic sclerosis, rheumatoid arthritis and myositis, long-term exposure to dusts, molds or bird proteins (hypersensitivity pneumonitis), some medicines, and radiation. In idiopathic pulmonary fibrosis, the most common form in older adults, no cause is found. Symptoms include breathlessness on exertion and a dry cough that lasts.
Lab tests linked to interstitial lung disease:
- Anti-Scl-70 (anti-topoisomerase I) antibodies: a marker of diffuse systemic sclerosis. A positive result is linked to a higher risk of ILD in people with scleroderma.
- ILD is diagnosed with a high-resolution CT scan of the chest and lung function tests, including the diffusing capacity (DLCO). Doctors also order autoimmune tests, such as ANA, rheumatoid factor, anti-CCP and myositis antibodies, and sometimes a bronchoscopy or lung biopsy.
How results are read:
- The pattern on high-resolution CT, together with history and blood tests, is often enough to identify the type of ILD.
- A positive anti-Scl-70 points to systemic sclerosis as the cause. A negative result doesn't rule out other autoimmune causes.
- Declining lung function or DLCO can suggest progression. Doctors read the change alongside symptoms and CT findings, and check for other explanations before changing treatment.
When to see a doctor:
- See a doctor about breathlessness on exertion that is getting worse, or a dry cough lasting more than 3 weeks.
- If you have systemic sclerosis or another connective tissue disease, ask about regular lung checks.
- Get emergency care for sudden severe breathlessness, blue lips or chest pain.
Clinical takeaway: interstitial lung disease is diagnosed with high-resolution CT and lung function tests, and autoimmune antibodies such as anti-Scl-70 help find the cause.
Biomarkers related to this condition
1 marker linked to this condition
Looking for a different marker? Browse all biomarkers →